Insulin resistant states such as NIDDM and obesity are characterized by a decrease in insulin stimulated glucose uptake. The insulin responsive glucose transporter GLUT 4, plays a major role in insulin stimulated glucose uptake in normal muscle and adipose cells. Although GLUT 4 is thought to be important in maintaining normal glucose homeostasis, it is not known whether alterations in GLUT 4 function will cause severe metabolic consequences. The goal of this proposal is to understand glucose metabolism in mice having no functional GLUT 4 and in mice where GLUT 4 is overexpressed in skeletal muscle. Two lines of genetically modified mice have been developed for this purpose. Mice which carry two disrupted alleles of GLUT 4 (Delta GLUT4/Delta GLUT4) have been established. The DeltaGLUT4/DeltaGLUT4 mice display post prandial hyperinsulinemia and represent a model for the study of insulin resistance similar to that seen in NIDDM and obesity. The other line of mice overexpressed GLUT 4 specifically in skeletal muscle (MLC GLUT4), the largest depot for post prandial glucose disposal. The MLC GLUT4 mice are hypersensitive to insulin. Mice genetically modified in GLUT4 will provide an animal paradigm for understanding glucose homeostasis, the response of glucose metabolism to insulin and the development of insulin resistance. Major questions which can be answered with the unique GLUT4 modified mice include: 1. Does the deficiency of the insulin responsive GLUT4 transporter cause diabetes? The rate of glucose clearance from the circulation can be compared in normal and DelatGLUT4/DeltaGLUT4 mice by euglycemic clamp and 2 deoxyglucose uptake experiments. Metabolites, hormones and enzyme activities of glucose homeostasis can be measured. 2. Does GLUT4 expression in skeletal muscle dictate whole body insulin sensitivity? The tissue patterns of muscle, adipose cell and liver enzyme expression can be compared in GLUT4 deficient and GLUT4 excess to provide unequivocal answers to the metabolic role of insulin responsive glucose transport effects. 3. Can the amount of GLUT4 expressed modify the response to nutritional or other stress? The insulin response of GLUT4 deficient and MLC GLUT4 mice can be compared in response to dietary stress (i.e. high fat or high carbohydrate diets) and to streptozotocin treatment to determine whether altered GLUT4 function will exacerbate or blunt the onset insulin resistance and obesity. 4. Does a tissue specific knockout of GLUT4 in skeletal muscle or adipose tissue have a different phenotype than a general GLUT4 knockout? The rate of glucose clearance from the blood of mice deficient in skeletal muscle or adipose tissue GLUT4 can be compared to Delta GLUT 4/Delta GLUT4 and normal mice to separate contributions of GLUT4 in skeletal muscle and adipose tissue to whole body insulin sensitivity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK047425-03S1
Application #
6052170
Study Section
Metabolism Study Section (MET)
Program Officer
Haft, Carol R
Project Start
1995-08-01
Project End
1999-03-31
Budget Start
1999-01-01
Budget End
1999-03-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Biochemistry
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Charron, Maureen J; Vuguin, Patricia M (2015) Lack of glucagon receptor signaling and its implications beyond glucose homeostasis. J Endocrinol 224:R123-30
Vuguin, P M; Charron, M J (2011) Novel insight into glucagon receptor action: lessons from knockout and transgenic mouse models. Diabetes Obes Metab 13 Suppl 1:144-50
Hartil, Kirsten; Vuguin, Patricia M; Kruse, Michael et al. (2009) Maternal substrate utilization programs the development of the metabolic syndrome in male mice exposed to high fat in utero. Pediatr Res 66:368-73
Gelling, Richard W; Vuguin, Patricia M; Du, Xiu Quan et al. (2009) Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass. Am J Physiol Endocrinol Metab 297:E695-707
Sinclair, Elaine M; Yusta, Bernardo; Streutker, Catherine et al. (2008) Glucagon receptor signaling is essential for control of murine hepatocyte survival. Gastroenterology 135:2096-106
Longuet, Christine; Sinclair, Elaine M; Maida, Adriano et al. (2008) The glucagon receptor is required for the adaptive metabolic response to fasting. Cell Metab 8:359-71
Kedees, Mamdouh H; Guz, Yelena; Vuguin, Patricia M et al. (2007) Nestin expression in pancreatic endocrine and exocrine cells of mice lacking glucagon signaling. Dev Dyn 236:1126-33
Ranalletta, Mollie; Du, Xiu Quan; Seki, Yoshinori et al. (2007) Hepatic response to restoration of GLUT4 in skeletal muscle of GLUT4 null mice. Am J Physiol Endocrinol Metab 293:E1178-87
Piroli, Gerardo G; Grillo, Claudia A; Reznikov, Leah R et al. (2007) Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus. Neuroendocrinology 85:71-80
Fueger, Patrick T; Li, Candice Y; Ayala, Julio E et al. (2007) Glucose kinetics and exercise tolerance in mice lacking the GLUT4 glucose transporter. J Physiol 582:801-12

Showing the most recent 10 out of 49 publications